8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2017 / Prospective longitudinal follow-up of a randomized controlled trial
Researchers evaluated 39 nonobese adults at 12 and 24 months after finishing the 2-year CALERIE 2 trial (25% calorie restriction vs. ad libitum control). Following an initial mean weight loss of 9.0 ± 0.6 kg in the CR group, participants regained only 54% of that weight 2 years post-intervention. Weight, percentage of body fat, and fat mass remained significantly lower than baseline and significantly below the control group throughout follow-up (P < 0.05). The CR group also maintained higher levels of dietary restraint and avoidance of specific foods.
Marlatt KL, Redman LM, Burton JH, et al. Am J Clin Nutr, 2017. PMID 28275127
2017 / Randomized controlled trial
In a randomized controlled trial of 65 adults with overweight or obesity and cardiometabolic conditions, an ad libitum whole food plant-based diet was compared to usual care. At 6 months, mean BMI reduction was significantly greater in the diet group (difference: 3.9 kg m-2, 95% CI ±1, P < 0.0001). Total cholesterol reduction did not significantly differ between groups unless dropouts were excluded (difference: 0.56 mmol l-1, P = 0.05).
Wright N, Wilson L, Smith M, et al. Nutr Diabetes, 2017. PMID 28319109
2017 / Randomized controlled trial
In a randomized trial with 683 participants, only individuals assigned to the genetic advice arm received information regarding their FTO genotype status. At 6 months, FTO risk allele carriers in this group lost more weight (-2.28 kg, 95% CI: -3.06 to -1.48 vs. -1.99 kg, 95% CI: -2.19 to -0.19; P = 0.037) and more waist circumference (-4.34 cm vs. -1.99 cm; P = 0.048) than nonrisk carriers.
Celis-Morales C, Marsaux CF, Livingstone KM, et al. Am J Clin Nutr, 2017. PMID 28381478
2017 / Combined analysis of two randomized crossover trials
Data from two randomized crossover trials including 43 healthy adults were combined to assess interindividual differences in 24-hour ad libitum energy intake (EI) following sleep restriction (3.5-4 hours in bed/night) versus habitual sleep (7-9 hours in bed/night). Large interindividual variations in EI changes (ΔEI) were observed, ranging from -813 to 1437 kcal/d. Only protocol order was associated with ΔEI (β = -568 kcal/d, 95% CI -921 to -215 kcal/d; P = 0.002), with participants undergoing habitual sleep first demonstrating greater increases in EI during sleep restriction (P = 0.01).
McNeil J, St-Onge MP Obesity (Silver Spring), 2017. PMID 28401667
2017 / Randomized controlled explorative pilot trial
In an explorative trial, patients with type 2 diabetes were randomized to a 7-day fasting program (Buchinger method, ~300 kcal/day liquids) followed by dietary advice, or to usual care with dietary advice only. Of 46 enrolled participants, 32 completed the 4-month trial. After 4 months, mean weight decreased by 3.5 kg in the fasting group compared to 2.0 kg in controls (p=0.03), accompanied by a greater reduction in abdominal circumference (p=0.001). Fasting also resulted in a significant decrease in systolic (p=0.01) and diastolic (p=0.003) blood pressure, as well as increased quality of life (p=0.04), while improvements in HbA1c, insulin, and HOMA-index were non-significant.
Li C, Sadraie B, Steckhan N, et al. Exp Clin Endocrinol Diabetes, 2017. PMID 28407662
2017 / Randomized clinical trial
In a 1-year randomized clinical trial of 100 obese adults, alternate-day fasting produced weight loss similar to daily calorie restriction at month 6 (-6.8% vs -6.8%) and month 12 (-6.0% vs -5.3%) relative to control. Blood pressure, heart rate, triglycerides, fasting glucose, and insulin resistance did not differ significantly between intervention groups. However, dropout was highest with alternate-day fasting (38%), and low-density lipoprotein cholesterol was significantly elevated at month 12 (11.5 mg/dL).
Trepanowski JF, Kroeger CM, Barnosky A, et al. JAMA Intern Med, 2017. PMID 28459931
2017 / Randomized double-blind crossover trial
In a randomized crossover trial, 44 healthy women ingested placebo or potato extract standardized to 15 mg or 30 mg potato protease inhibitor II one hour before a 390 kcal breakfast. Both doses significantly lowered postprandial hunger, prospective consumption, and desire to eat while increasing fullness. The 15 mg dose significantly increased plasma cholecystokinin levels over three hours, with no significant differences observed in glucose or insulin.
Zhu Y, Lasrado JA, Hu J Food Funct, 2017. PMID 28485429
2017 / Randomized, double-blind, crossover trial
In a randomized, double-blind, crossover study, 12 normoglycaemic overweight or obese men received rectal infusions of SCFA mixtures high in acetate (HA), propionate (HP), butyrate (HB), or placebo during fasting and postprandial conditions. All three SCFA mixtures increased fasting fat oxidation (P < 0.01), while resting energy expenditure increased following HA and HP compared to placebo (P < 0.05). Furthermore, all three SCFA mixtures increased fasting and postprandial plasma PYY concentrations and attenuated fasting free glycerol concentrations compared with placebo (P < 0.05).
Canfora EE, van der Beek CM, Jocken JWE, et al. Sci Rep, 2017. PMID 28539646
2017 / Randomized controlled trial
In a randomized trial, 74 individuals with type 2 diabetes consumed either a calorie-restricted vegetarian diet or an isocaloric conventional anti-diabetic diet for 6 months. Total leg area decreased more in the vegetarian group (-13.6 cm2 vs -9.9 cm2; p < 0.001), and subfascial fat was reduced only with the vegetarian diet (-0.82 cm2 vs -0.44 cm2; p = 0.04). Reductions in subfascial and subcutaneous fat correlated with improvements in fasting glucose and beta-cell insulin sensitivity.
Kahleova H, Klementova M, Herynek V, et al. J Am Coll Nutr, 2017. PMID 28604251
2017 / Controlled trial
Patients with metabolic syndrome were assigned to a control group receiving healthy diet instructions or a supplemented group receiving healthy diet instructions plus 14 g of natural goji berry daily for 45 days. After 45 days, the supplemented group showed a significant reduction in transaminases and an improvement in lipid profile. Compared with the control group, the supplemented group had a significant reduction in waist circumference, along with increased glutathione and catalase levels associated with reduced lipid peroxidation.
de Souza Zanchet MZ, Nardi GM, de Oliveira Souza Bratti L, et al. Oxid Med Cell Longev, 2017. PMID 28685012
2017 / Crossover metabolic chamber trial
Nine young female subjects completed 24-hour indirect calorimetry measurements in a metabolic chamber under sedentary conditions and with 60 minutes of exercise before breakfast at 50% of VO2max, with energy intake adjusted to maintain 24-hour energy balance. Compared to the sedentary condition, exercise before breakfast increased 24-hour fat oxidation (519 ± 37 vs. 400 ± 41 kcal/day). A transient deficit in both relative energy balance and carbohydrate balance was observed before breakfast, with greater deficits in the exercise trial.
Iwayama K, Kawabuchi R, Nabekura Y, et al. PLoS One, 2017. PMID 28692687
2017 / Randomized crossover trial
In a randomized crossover trial, 33 adults chewed sugar-free gum for three 20-minute sessions or did not chew gum across test days. Fasting hunger ratings were significantly lower on the gum-chewing day compared to the control day (P = 0.01). Participants also consumed significantly less pasta at lunch, reducing meal intake by 41 g and 68 kcals (P = 0.03).
Melanson KJ, Kresge DL Appetite, 2017. PMID 28733151
2017 / Randomized double-blind crossover trial
In a randomized cross-over trial, 17 obese adults with radiographic knee osteoarthritis consumed 50 g per day of reconstituted freeze-dried strawberries or a control beverage for 12 weeks each. Strawberry treatment significantly reduced interleukin-6, interleukin-1beta, and matrix metalloproteinase-3 compared to control (all p < 0.05). Strawberries also lowered intermittent, constant, and total pain along with disability scores, while leaving C-reactive protein, nitrite, glucose, and lipids unchanged.
Schell J, Scofield RH, Barrett JR, et al. Nutrients, 2017. PMID 28846633
2017 / Randomized controlled trial
In a trial of 30 postmenopausal women, participants were randomly allocated to Nordic walking or traditional walking training for 40-50 minutes daily, thrice weekly. Nordic walking increased circulating VEGF more than traditional walking (p = 0.041). Both regimens lowered weight (p = 0.023), body mass index (p = 0.024), and hip circumference (p = 0.001), while traditional walking produced a greater decrease in arm fat index (p < 0.011).
Izzicupo P, D'Amico MA, Di Blasio A, et al. Climacteric, 2017. PMID 28920458
2017 / Randomized crossover trial
A randomized crossover study in 13 healthy adults tested the metabolic effects of consuming 5 g of d-allulose versus 10 mg of aspartame before a test meal. D-allulose significantly increased the area under the curve for postprandial fat oxidation compared with control (10.5 ± 0.4 vs 9.6 ± 0.3 kJ·4 h·kg-1, P < 0.05) and reduced carbohydrate oxidation (8.1 ± 0.5 vs 9.2 ± 0.5 kJ·4 h·kg-1, P < 0.05). Plasma glucose levels were also significantly lower after d-allulose ingestion.
Kimura T, Kanasaki A, Hayashi N, et al. Nutrition, 2017. PMID 28935140
2017 / Randomized crossover trial
A randomized crossover study in 24 subjects examined the effects of three mid-morning snacks: yogurt alone, yogurt with 7 g chia seed, and yogurt with 14 g chia seed across different test days. Visual analog scale scores revealed significantly lower hunger (P = 0.033), prospective food consumption (P = 0.031), amounts of food that could be consumed (P = 0.017), desire for sugary foods (P = 0.015), and higher satiety (P = 0.031) on days with 7 g and 14 g chia seed. Energy intake during the subsequent ad libitum lunch was also significantly lower following consumption of yogurt with 7 g or 14 g chia seed (P = 0.037).
Ayaz A, Akyol A, Inan-Eroglu E, et al. Nutr Res Pract, 2017. PMID 28989578
2017 / Randomized controlled trial
In the CALERIE trial, 218 healthy, nonobese adults were randomized 2:1 to 25% calorie restriction (CR) or an ad libitum (AL) control for 2 years. The CR group achieved an average of 11.9% ± 0.7% CR and lost 7.7 ± 0.4 kg, while AL gained 0.2 ± 0.5 kg. Absolute VO2max and absolute knee flexor and extensor strength decreased at 1 and 2 years with CR, but relative to body mass, VO2max increased (+2.2 ± 0.4 at 1 yr; +1.9 ± 0.5 mL·kg⁻¹·min⁻¹ at 2 yr) alongside increases in relative strength, treadmill time, and workload. No changes occurred in VO2max expressed relative to lean body mass or leg lean mass.
Racette SB, Rochon J, Uhrich ML, et al. Med Sci Sports Exerc, 2017. PMID 29045325
2017 / 6-month randomized controlled trial
A 6-month randomized controlled trial evaluated 100 overweight and obese subjects assigned to alternate day fasting (ADF), daily calorie restriction (CR), or a control group. By month 6, body weight decreased similarly in ADF (-7.8±1.2%) and CR (-8.8±1.5%) compared to controls (P < 0.001). Lean mass, total body bone mineral content, total body bone mineral density, osteocalcin, bone alkaline phosphatase, and CTX remained unchanged across all groups. IGF-1 increased in the CR group (P < 0.01) but showed no change in the ADF or control groups, and subgroup analyses by menopausal status revealed no differences.
Barnosky A, Kroeger CM, Trepanowski JF, et al. Nutr Healthy Aging, 2017. PMID 29276795
2017 / Randomized, double-blind, placebo-controlled trial
In an 8-week randomized, double-blind, placebo-controlled trial, 84 patients with coronary artery disease were assigned to receive daily supplements of 30 mg saffron aqueous extract (SAE), 30 mg crocin, or placebo. Decreases in BMI, waist circumference, and fat mass were significantly greater in the SAE group than the crocin group (P < 0.001). Both SAE and crocin led to significant decreases in energy and dietary intake (P < 0.001 and P = 0.046, respectively) and appetite (P < 0.001 and P = 0.029, respectively), while placebo showed no change. No significant differences were observed in lipid profile parameters at the end of the study.
Abedimanesh N, Bathaie SZ, Abedimanesh S, et al. J Cardiovasc Thorac Res, 2017. PMID 29391933
2017 / Dose-response randomized, controlled, single-blind parallel trial
A 12-week randomized controlled trial evaluated the effects of 25 g/d and 50 g/d of quinoa compared with a control group in 50 overweight and obese participants. Body composition, nutrient intake, and total, LDL, and HDL cholesterol were not significantly altered (P > 0.05). In the 50-g quinoa group, mean serum triglycerides dropped significantly from 1.14 to 0.72 mmol/L at 12 weeks (P < 0.05), and metabolic syndrome prevalence fell by 70%. In the 25-g group, metabolic syndrome prevalence decreased by 40% (from n = 7 at baseline to n = 4 at 12 weeks), with no significant triglyceride changes observed in the control or 25-g groups.
Navarro-Perez D, Radcliffe J, Tierney A, et al. Curr Dev Nutr, 2017. PMID 29955719
2016 / Open-label randomized crossover pilot trial
A 14-day, open-label randomized crossover pilot study in 10 older overweight or obese males evaluated the effect of 45 g/d lyophilized black raspberries on postprandial inflammation after a high-fat, high-calorie meal. Consumption of black raspberries significantly lowered serum IL-6 AUC to 34.3 ± 7.6 pg·mL⁻¹·h⁻¹ compared with 42.4 ± 17.9 pg·mL⁻¹·h⁻¹ for the meal alone (P = 0.03). No significant differences were observed for serum CRP and TNF-α AUC.
Sardo CL, Kitzmiller JP, Apseloff G, et al. Am J Ther, 2016. PMID 23982695
2016 / Randomized controlled trial
In a randomized, double-blind trial, 80 obese women received 2 g daily of ginger powder or placebo for 12 weeks. Ginger supplementation significantly decreased body mass index, serum insulin, and HOMA-IR index, while increasing QUICKI values compared to placebo. Decreases in leptin, resistin, and glucose occurred in both cohorts without significant differences between groups, whereas body composition and adiponectin concentrations remained unchanged.
Ebrahimzadeh Attari V, Ostadrahimi A, Asghari Jafarabadi M, et al. Eur J Nutr, 2016. PMID 26318445
2016 / Randomized controlled trial
Sixty-one overweight and obese older adults underwent a 12-week, 25% energy intake restriction and were randomized to either a high-protein diet (1.7 g/kg/day, n=31) or normal-protein diet (0.9 g/kg/day, n=30). Body weight declined similarly in both groups (-8.9±2.9 kg in high protein vs -9.1±3.4 kg in normal protein; P=0.584). Lean body mass declined by 1.8±2.2 kg and 2.1±1.4 kg, respectively, with no significant difference between groups (P=0.213). Leg strength decreased (-8.8±14.0 kg vs -8.9±12.8 kg; P=0.689) and 400 m walking speed improved in both groups with no between-group differences.
Backx EM, Tieland M, Borgonjen-van den Berg KJ, et al. Int J Obes (Lond), 2016. PMID 26471344
2016 / Randomized controlled trial
In an eight-week randomized controlled study, 20 overweight and physically inactive women were allocated to either weekly Zumba fitness classes or habitual activity. Compared with controls, the Zumba group experienced a significant increase in maximal oxygen uptake of 3.1 mL·kg⁻¹·min⁻¹ and a 1.2% decrease in body fat percentage (p < 0.05). Interleukin-6 and white blood cell count also dropped significantly by 0.4 pg·mL⁻¹ and 2.1 × 10⁹ cells·L⁻¹, respectively (p < 0.01).
Domene PA, Moir HJ, Pummell E, et al. J Sports Sci, 2016. PMID 26571136